Conditioning with melphalan 200 mg/m(2) and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care

OBJECTIVES: Despite the effectiveness of newer drugs for the treatment of multiple myeloma (MM), the outcomes are further improved by subsequent autologous stem cell transplantation (ASCT). Data on effectiveness in older patients are limited. We compared outcomes in patients aged 65–75 years dependi...

Descripción completa

Detalles Bibliográficos
Autores principales: Afram, Gabriel, Chaireti, Roza, Uttervall, Katarina, Luong, Vincent, Lund, Johan, Kashif, Muhammad, Gahrton, Gösta, Alici, Evren, Nahi, Hareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826071/
https://www.ncbi.nlm.nih.gov/pubmed/36066204
http://dx.doi.org/10.1111/ejh.13861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826071/
https://www.ncbi.nlm.nih.gov/pubmed/36066204
http://dx.doi.org/10.1111/ejh.13861

Ejemplares similares